Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
14,868,974
-
Share change
-
+901,680
-
Total reported value
-
$219,315,765
-
Put/Call ratio
-
39%
-
Price per share
-
$14.75
-
Number of holders
-
79
-
Value change
-
+$13,878,644
-
Number of buys
-
41
-
Number of sells
-
35
Institutional Holders of CONCERT PHARMACEUTICALS INC - COM (CNCE) as of Q3 2017
As of 30 Sep 2017,
CONCERT PHARMACEUTICALS INC - COM (CNCE) was held by
79 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,868,974 shares.
The largest 10 holders included
BVF INC/IL, GREAT POINT PARTNERS LLC, INGALLS & SNYDER LLC, BlackRock Inc., VANGUARD GROUP INC, FRANKLIN RESOURCES INC, Lyon Street Capital, LLC, RENAISSANCE TECHNOLOGIES LLC, Alyeska Investment Group, L.P., and SENZAR ASSET MANAGEMENT, LLC.
This page lists
79
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.